Your Search for adriamycin matched 179 Documents (Page 1 of 6).
Results Indexed by relevance.

1. The influence of adriamycin on the CD4+ and CD8+ cells in the course of trichinellosis in mice. (51%)
Abstract: The effect of adriamycin on the behaviour of CD4+ and CD8+ cells in the course of trichinellosis in mice has been studied. The animals infected with 200 larvae per mouse were administered intraperitoneally adriamycin (Adriblastin from Farmitalia) at 1st and 28th day post infection (dpi), in a dosis of 0.2 mg. The mice ...
http://www.aegis.org/aidsline/1995/apr/m9540123.html
File Name: m9540123.html, Size: 9KB, Last Modified: Friday, April 28, 1995 at 8:12:04 PM

2. Combined therapy with adriamycin and vincristin in advanced Kaposi sarcoma. (51%)
Abstract: OBJECTIVE: To evaluate efficacy and tolerance of combined therapy with Adriamycin and Vincristin in advanced AIDS Kaposi sarcoma (KS). METHODS: 24 patients with extensive KS (stage II=2, III=14, IV=8; subtype A=14, B=10) including 14 patients with lymphoedema) were treated with adriamycin 30 mg/m2 + vincristin 1,2 mg ...
http://www.aegis.org/aidsline/1991/dec/m91c1665.html
File Name: m91c1665.html, Size: 10KB, Last Modified: Saturday, December 28, 1991 at 8:12:04 PM

3. AEGiS-07IAC: Combined therapy with adriamycin and vincristin in advanced Kaposi sarcoma. (51%)
Abstract: <p><b>OBJECTIVE</b>: To evaluate efficacy and tolerance of combined therapy with Adriamycin and Vincristin in advanced AIDS Kaposi sarcoma (KS).</p> <p><b>METHODS</b>: 24 patients with extensive KS (stage II=2, III=14, IV=8; subtype A=14, B=10) including 14 patients with lymphoedema) were treated with adriamycin 30 ...
http://www.aegis.org/conferences/iac/1991/wb2379.html
File Name: wb2379.html, Size: 6KB, Last Modified: Sunday, June 16, 1991 at 8:12:04 PM

4. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway. (38%)
Abstract: The WAF1/CIP1 protein has been identified as a downstream mediator of the tumor suppressor p53 in regulating cell cycle progression through a G1-phase check-point. Recent work has implicated the functional status of p53 as a critical determinant in the apoptotic response of certain cell lines to DNA damaging agents. B ...
http://www.aegis.org/aidsline/1996/apr/m9640103.html
File Name: m9640103.html, Size: 10KB, Last Modified: Sunday, April 28, 1996 at 8:12:04 PM

5. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. (25%)
Abstract: PURPOSE: Kaposi s sarcoma occurs commonly in patients with the acquired immunodeficiency syndrome (AIDS). Kaposi s sarcoma may remain localized or disseminate to involve visceral organs such as the lungs. Disseminated pulmonary involvement, when it occurs, is often fatal. Effective therapy may improve survival in such ...
http://www.aegis.org/aidsline/1989/oct/m89a0014.html
File Name: m89a0014.html, Size: 10KB, Last Modified: Wednesday, January 07, 2009 at 5:29:25 AM

6. KAPOSI'S SARCOMA: CHEMOTHERAPY (25%)
Abstract: The background of chemotherapy in non-AIDS-related Kaposi s sarcoma (KS) is summarized, agents that have been used in patients (pts) with AIDS are discussed, and management guidelines are offered. The following therapeutic agents are discussed: vinblastine, vincristine, etoposide (VP-16), alternating vinblastine and v ...
http://www.aegis.org/aidsline/1989/apr/m8940673.html
File Name: m8940673.html, Size: 9KB, Last Modified: Wednesday, January 07, 2009 at 5:22:27 AM

7. Further experience with Kaposi's sarcoma in Uganda. (25%)
Abstract: Four Ugandan patients (1 women, 3 men) with generalized Kaposi s sarcoma (KS) were seen in the Uganda Cancer Institute between October 1983 and December 1984. They presented with generalized lymphadenopathy, plaques/nodules on the body, general swelling of the head, oral and visceral involvement and respiratory distre ...
http://www.aegis.org/aidsline/1986/sep/m8690112.html
File Name: m8690112.html, Size: 8KB, Last Modified: Wednesday, January 07, 2009 at 5:01:26 AM

8. AEGiS-15IAC: Treatment of Kaposi's Sarcoma with Liposomal Daunorrubicin (daunoxome) is associated with less side effects and similar efficacy compared to other treatment options. (25%)
Abstract: BACKGROUND: Our objectives were to compare the efficacy and adverse effects of a lipossomal form of daunorrubicin (daunoxome) with other agents in AIDS patients with KS admitted to the Centro de Referencia em DST/AIDS [CRTA]- a specialized public facility for AIDS treatment in Sao Paulo/ Brazil METHODS: From 1 ...
http://www.aegis.org/conferences/iac/2004/c12648.html
File Name: c12648.html, Size: 7KB, Last Modified: Monday, July 12, 2004 at 6:29:23 AM

9. La Red de Informacion del SIDA: Doxil (doxorubicina liposomal) en espaņol (25%)
Abstract: Hojas Sueltas. de. La RED de Información del SIDA. Doxil (doxorubicina liposomal). Doxil es un nuevo tratamiento contra el. sarcoma de Kaposi o KS. en íngles. El KS es un tipo de cáncer que los hombres con. VIH. pueden desarrollar, el mismo es muy raramente visto en mujeres. Aunque el KS mayormente afecta la pi ...
http://www.aegis.org/factshts/network/lared/simple/doxil.html
File Name: doxil.html, Size: 7KB, Last Modified: Tuesday, April 16, 2002 at 5:55:38 PM

10. Antioxidative effect of melatonin in rat brain oxidative stress induced by Adriamycin. (25%)
Abstract: The effect of melatonin administration on the oxidative stress induced by a high dose of Adriamycin (AD, doxorubicin hydrochlor ...
http://www.aegis.org/pubs/medline/1998/jan/m9814670.html
File Name: m9814670.html, Size: 6KB, Last Modified: Saturday, January 31, 1998 at 10:00:00 PM

11. Characteristics of mutagenesis by bleomycin and adriamycin in Salmonella typhimurium: action of catalase. (25%)
Abstract: The influence of catalase activity in adriamycin and bleomycin mutagenesis was investigated in Salmonella typhimurium TA98 and ...
http://www.aegis.org/pubs/medline/1998/jan/m9811355.html
File Name: m9811355.html, Size: 4KB, Last Modified: Saturday, January 31, 1998 at 10:00:00 PM

12. Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line. (25%)
Abstract: We have demonstrated that low-level expression of P-glycoprotein (PGP), detectable by reverse transcriptase polymerase chain re ...
http://www.aegis.org/pubs/medline/1998/jan/m9813596.html
File Name: m9813596.html, Size: 5KB, Last Modified: Saturday, January 31, 1998 at 10:00:00 PM

13. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma. (25%)
Abstract: After administration of Adriamycin, bleomycin, vincristine (ABV) as palliative chemotherapy in advanced AIDS-related Kaposi s sarcoma (AIDS.KS) patients with low Karnosfsky performance scores, the authors attempted to estimate the overall biological cost/benefit relating to the disease. The authors analyzed data from ...
http://www.aegis.org/aidsline/1997/jun/m9761096.html
File Name: m9761096.html, Size: 9KB, Last Modified: Saturday, June 28, 1997 at 8:12:04 PM

14. AEGiS-11IAC: Adriamycin, bleomycin and vinblastine (ABV) chemotherapy in the treatment of AIDS-related Kaposi's sarcoma (KS). (25%)
Abstract: To evaluate the efficacy and toxicity of a therapeutic scheme with ABV in association with rHuG-CSF for the treatment of poor risk AIDS - related KS. <p><b>METHODS</b>: HIV-positive patients were enrolled in the study if they had biopsy-proven KS with either visceral involvement or tumor associated edema and/or ulcer ...
http://www.aegis.org/conferences/iac/1996/web3238.html
File Name: web3238.html, Size: 7KB, Last Modified: Sunday, July 07, 1996 at 8:12:04 PM

15. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. (25%)
Abstract: OBJECTIVE: To determine the toxicity and maximum tolerated dose of doxorubicin (adriamycin) in combination with fixed doses of bleomycin, vincristine (ABV) and zidovudine in patients with advanced AIDS-related Kaposi s sarcoma. PATIENTS AND METHODS: Twenty-six HIV-seropositive men with Kaposi s sarcoma were treated da ...
http://www.aegis.org/aidsline/1995/jun/m9560048.html
File Name: m9560048.html, Size: 10KB, Last Modified: Wednesday, June 28, 1995 at 8:12:04 PM

16. AEGiS-Glasgow [13.2] THE TREATMENT OF KAPOSI'S SARCOMA WITH CYTOTOXIC AGENTS (25%)
Abstract: In the light of the round-table discussion of other types of treatment,the chemotherapy of KS will be discussed both in terms of its indications and pitfalls. New cytotoxic agents such as paclitaxel are also under investigation and will be discussed. ...
http://www.aegis.org/conferences/hiv-glasgow/1994/13-2.html
File Name: 13-2.html, Size: 6KB, Last Modified: Friday, November 18, 1994 at 8:12:04 PM

17. Immune reactivity modifications related to uptake of Adriamycin by hematopoietic cells (Meeting abstract). (25%)
Abstract: The purpose of this study was to evaluate the relationship between Adriamycin (ADM) uptake by murine spleen and thymus cells and cellular immune parameters after a single low-dose (5 mg/kg iv) ADM injection. ADM treatment resulted in reduced thymic cellularity; the most sensitive cells being CD3(lo)4+8+ T cells decrea ...
http://www.aegis.org/aidsline/1993/nov/m93b5839.html
File Name: m93b5839.html, Size: 8KB, Last Modified: Sunday, November 28, 1993 at 8:12:04 PM

18. AEGiS-09IAC: Adriamycin, bleomycin, vindesine (ABV) in 40 HIV infected patients (pts) with advanced Kaposi's sarcoma (KS). GICAT (Italian Cooperative Group on AIDS and Tumors). (25%)
Abstract: Between January 1991 and December 1992, 40 HIV infected pts (39 males and 1 female, median age 38 years, range 22-61) with advanced KS (20 with stage III and 15 with stage IV according to NYU classification) were enrolled in the study. Thirty (75%) were homo-bisexual men, 4 (10%) heterosexuals, 4 (10%) intravenous drug ...
http://www.aegis.org/conferences/iac/1993/pob121559.html
File Name: pob121559.html, Size: 6KB, Last Modified: Sunday, June 06, 1993 at 8:12:04 PM

19. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. (25%)
Abstract: OBJECTIVE: To determine the maximum tolerated dose of granulocyte-macrophage colony-stimulating factor (GM-CSF) that would reduce the severity and duration of neutropenia from combination cytotoxic chemotherapy in the treatment of AIDS-related Kaposi s sarcoma (KS). DESIGN: Phase I, dose escalation. SETTING: Outpatien ...
http://www.aegis.org/aidsline/1993/may/m9350634.html
File Name: m9350634.html, Size: 11KB, Last Modified: Friday, May 28, 1993 at 8:12:04 PM

20. Liposome Encapsulated Cancer Drug Shows Enhanced Delivery in AIDS-KS Patients; Significant Efficacy Demonstrated by Novel Lesion Measurement Technique (25%)
Abstract: Orlando, Fla.--A new liposomal compound of the well-known anti -cancer agent doxorubicin hydrochloride has been found to deliver more drug to the disease site than standard therapy in treating AIDS patients with Kaposi s Sarcoma (KS), according to findings presented yesterday at the 29th annual meeting of the American ...
http://www.aegis.org/news/ads/1993/ad930929.html
File Name: ad930929.html, Size: 10KB, Last Modified: Wednesday, May 19, 1993 at 3:00:00 PM

21. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. (25%)
Abstract: Adriamycin (ADR) is an anticancer drug commonly used in the treatment of HIV-related cancers. Due to its effect on DNA metabolism, ADR might be able to modulate HIV replication in monocyte-macrophages (M/M), resting cells potentially less sensitive to the toxic effect of this drug. Thus, we assessed the efficacy of AD ...
http://www.aegis.org/aidsline/1992/dec/m92c0026.html
File Name: m92c0026.html, Size: 10KB, Last Modified: Monday, December 28, 1992 at 8:12:04 PM

22. ABV chemotherapy and rhGCSF in two HIV-1 infected patients suffering from Kaposi's sarcoma. (25%)
Abstract: OBJECTIVE: In order to decrease hematologic toxicity of combined chemotherapy (adriamycin, bleomycin, vincristine) of AIDS related Kaposi s sarcoma (KS), we additionally administered recombinant human granulocyte colony stimulating factor (rhGCSF, Neupogen). METHODS: 24 hours after administration of ABV chemotherapy ( ...
http://www.aegis.org/aidsline/1991/dec/m91c1914.html
File Name: m91c1914.html, Size: 9KB, Last Modified: Saturday, December 28, 1991 at 8:12:04 PM

23. Adriamycin selectively inhibits HIV replication in resting macrophages. (25%)
Abstract: OBJECTIVE: Evaluate the anti-HIV activity of adriamycin (ADR), an anticancer drug also inhibitor of some viral reverse transcriptases (RT), in monocyte/macrophages (M/M). METHODS: Five-day old blood-derived M/M were exposed to a monocytotropic HIV in the presence of ADR. P24 antigen, RT, and syncytia formation were th ...
http://www.aegis.org/aidsline/1991/dec/m91c2318.html
File Name: m91c2318.html, Size: 10KB, Last Modified: Saturday, December 28, 1991 at 8:12:04 PM

24. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. (25%)
Abstract: PURPOSE: Patients with acquired immunodeficiency syndrome (AIDS)-related epidemic Kaposi s sarcoma generally respond well to cytotoxic chemotherapy. However, due to the associated myelosuppression, these patients are at risk for developing complicating infections that may affect survival. We therefore conducted a mult ...
http://www.aegis.org/aidsline/1991/jul/m9170053.html
File Name: m9170053.html, Size: 11KB, Last Modified: Sunday, July 28, 1991 at 8:12:04 PM

25. AEGiS-07IAC: ABV chemotherapy and rhGCSF in two HIV-1 infected patients suffering from Kaposi's sarcoma. (25%)
Abstract: <p><b>OBJECTIVE</b>: In order to decrease hematologic toxicity of combined chemotherapy (adriamycin, bleomycin, vincristine) of AIDS related Kaposi s sarcoma (KS), we additionally administered recombinant human granulocyte colony stimulating factor (rhGCSF, Neupogen).</p> <p><b>METHODS</b>: 24 hours after administra ...
http://www.aegis.org/conferences/iac/1991/wb2129.html
File Name: wb2129.html, Size: 5KB, Last Modified: Sunday, June 16, 1991 at 8:12:04 PM

26. AEGiS-07IAC: Adriamycin selectively inhibits HIV replication in resting macrophages. (25%)
Abstract: <p><b>OBJECTIVE</b>: Evaluate the anti-HIV activity of adriamycin (ADR), an anticancer drug also inhibitor of some viral reverse transcriptases (RT), in monocyte/macrophages (M/M).</p> <p><b>METHODS</b>: Five-day old blood-derived M/M were exposed to a monocytotropic HIV in the presence of ADR. P24 antigen, RT, and ...
http://www.aegis.org/conferences/iac/1991/wa1071.html
File Name: wa1071.html, Size: 5KB, Last Modified: Sunday, June 16, 1991 at 8:12:04 PM

27. Pulmonary Kaposi's sarcoma (KS) in patients with HIV infection. (25%)
Abstract: OBJECTIVE: To determine the features and responses to treatment of pulmonary KS in patients with HIV infection. METHODS: Forty-one HIV positive patients (39 homosexual men, 2 heterosexual African women). Twenty four (58%) patients have had previous opportunistic infections. RESULTS: 1) Extra pulmonary organs involveme ...
http://www.aegis.org/aidsline/1990/dec/m90c1005.html
File Name: m90c1005.html, Size: 9KB, Last Modified: Friday, December 28, 1990 at 8:12:04 PM

28. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification. (25%)
Abstract: We used an endoscopic method of quantification to evaluate the response of symptomatic gastrointestinal Kaposi s sarcoma (KS) prospectively in seven patients with acquired immune deficiency syndrome (AIDS) who were participating in chemotherapy trials for extensive cutaneous KS. The sums of the diameters of KS lesions ...
http://www.aegis.org/aidsline/1990/nov/m90b0050.html
File Name: m90b0050.html, Size: 10KB, Last Modified: Wednesday, November 28, 1990 at 8:12:04 PM

29. AEGiS-06IAC: Pulmonary Kaposi's sarcoma (KS) in patients with HIV infection. (25%)
Abstract: <p><b>OBJECTIVE</b>: To determine the features and responses to treatment of pulmonary KS in patients with HIV infection.</p> <p><b>METHODS</b>: Forty-one HIV positive patients (39 homosexual men, 2 heterosexual African women). Twenty four (58%) patients have had previous opportunistic infections.</p> <p><b>RESULTS ...
http://www.aegis.org/conferences/iac/1990/2091.html
File Name: 2091.html, Size: 5KB, Last Modified: Wednesday, June 20, 1990 at 8:12:04 PM

30. DOXIL superior for KS. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 2714. (12%)
Abstract: Initial analysis of phase II data on DOXIL shows that it appears to be a more effective treatment for AIDS-related Kaposi s sarcoma (KS) than chemotherapy with Adriamycin, Bleomycin, and Vincristine (ABV) combination. DOXIL is a long-circulating liposome form of the an ...
http://www.aegis.org/aidsline/1996/jun/m9660442.html
File Name: m9660442.html, Size: 8KB, Last Modified: Thursday, January 08, 2009 at 1:03:47 AM

 
1 2 3 4 5 6 Next
 
AEGiS Search Engine. Status: The Index is up to date.